Using Salsalate to Target Adipocyte Macrophage InfiltrationTrial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained AnemiaAngiotensin II and Chronic Inflammation in Persistent Microvascular Dysfunction Following PreeclampsiaTreating Inflammation in Polycystic Ovary Syndrome to Ameliorate Ovarian DysfunctionSalsalate as an Adjunctive Treatment for Patients With SchizophreniaEvaluation of Oral Lipid Ingestion in Relation to Ovarian Androgen Secretion in Polycystic Ovary Syndrome (PCOS)Oral Peri-operative TIming of Metformin (or) Salsalate to Improve Non-cardiac Surgery Glucose Control
P4844
The ancient drug salicylate directly activates AMP-activated protein kinaseAMPK: a target for drugs and natural products with effects on both diabetes and cancerSalicylate downregulates 11β-HSD1 expression in adipose tissue in obese mice and in humans, mediating insulin sensitizationSalsalate attenuates free fatty acid-induced microvascular and metabolic insulin resistance in humansSalicylate (salsalate) in patients with type 2 diabetes: a randomized trial.Effects of salsalate therapy on recovery from vascular injury in female Zucker fatty ratsSalsalate and Adiponectin Improve Palmitate-Induced Insulin Resistance via Inhibition of Selenoprotein P through the AMPK-FOXO1α Pathway.Modeling diabetes disease progression and salsalate intervention in Goto-Kakizaki rats.Pharmacokinetics of salsalate and salicylic acid in normal and diabetic ratsA randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose toleranceTargeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD).Is there a role for immune and anti-in-flammatory therapy in type 2 diabetes?Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells.AMPK: mediating the metabolic effects of salicylate-based drugs?Stimulation of human whole-body energy expenditure by salsalate is fueled by higher lipid oxidation under fasting conditions and by higher oxidative glucose disposal under insulin-stimulated conditions.Salsalate is poorly tolerated and fails to improve endothelial function in virologically suppressed HIV-infected adults.Beta-lactamase inhibitory component from the roots of Fissistigma cavaleriei.Open-label salsalate for the treatment of pre-diabetes in people with schizophrenia.Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes.Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A.Reduction of insulin resistance and plasma glucose level by salsalate treatment in persons with prediabetes.Full-spectrum antioxidant therapy featuring astaxanthin coupled with lipoprivic strategies and salsalate for management of non-alcoholic fatty liver disease.[Benefits and risks of current pharmacotherapy in the treatment of type 2 diabetes]Summaries for patients. Salsalate for type 2 diabetes mellitus
P921
Q61894371-25891659-1323-4280-941E-496D25BCBE9FQ61956889-DFB98D41-51F7-4A46-8AFA-445C4C7178A9Q62810801-915158EF-7EC7-4BD7-A362-780D2F43B49FQ63012895-A6285651-6FF5-4B7A-ACEE-400D9862B7A6Q63315521-7A5C9265-C856-42DA-9EBF-EF673D8919BFQ63321095-38B6DAF1-BE18-4462-9897-DE341853776DQ63581948-497E82E1-519E-47E6-B0EB-8F88E5DA13C1
P4844
Q24630758-084D3EF6-E2A4-436F-BDF0-198065AC983EQ27002908-C9A4EF4E-1F22-47E3-89AC-58287163EF32Q28260504-2D4B8032-1BCA-41EB-B3FC-D1BB1A400A23Q30426185-64578279-A26E-4E73-8D2E-C829E1D13B4CQ34027442-EFE66C8C-8B49-4440-84EE-3B91545EF501Q34355389-FE2DBA80-9312-4788-9EED-AB42B6ACC8F1Q34794081-1978C37D-EC9F-449F-9D6B-528B31ABA40CQ35579519-75D396C9-58E9-4C53-89D3-D0F47C0DA9C5Q36230231-197A9D4F-5E03-4AA1-8A2A-4561AB89EB58Q37101773-41E99863-491E-4FBC-8155-F7314F154FA2Q37331296-A40CD143-9318-4ED7-B73F-33ECC073606BQ37868922-05BE3DD9-BF31-41B2-9ECA-497D3399FAD9Q38717713-B2BAF2E4-7796-4226-BB33-8491B6EF1EF5Q40240715-F8D0380D-27BD-44DC-BBCB-91D6DEA6685CQ42483437-7AB29D76-7664-4A89-83E5-39E30E107D8AQ42976774-3C9B4422-CAEC-43C5-B9AF-BC324A371A5DQ43277759-FBA6DDA2-49E9-4E30-B6FD-E45FA3640731Q45340195-5B247320-E52C-4E97-B628-15776B3CA298Q46003964-772259EE-4297-4B99-90E2-2A3E628B8FE7Q47774433-B2734992-0D4B-4A6A-9F3D-94B10EC881F9Q51354215-3F6FFA07-C0EA-4317-AC38-CED68274E7B3Q54573809-772EF6F7-BE1D-4F8C-A9FE-0A956A223E9CQ83568914-040CFD22-93B6-4220-8FD8-FBB49B3C3CE2Q87030279-B4AA359E-D6F0-49E7-AF16-2CFD7FC0E4C7
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Salsalat
@sh
Salsalate
@nl
Salsalato
@es
Salsalato
@it
salsalad
@cy
salsalat
@nb
salsalat
@nn
salsalat
@sv
salsalate
@en
salsalate
@vi
type
label
Salsalat
@sh
Salsalate
@nl
Salsalato
@es
Salsalato
@it
salsalad
@cy
salsalat
@nb
salsalat
@nn
salsalat
@sv
salsalate
@en
salsalate
@vi
altLabel
2-Carboxyphenyl salicylate
@en
Disalcid
@en
Disalicylic acid
@en
Disalicylsaeure
@en
O-Salicylcylsalicylsaeure
@en
O-Salicylsalicylic acid
@cy
O-Salicylsalicylic acid
@en
Salicylic acid bimolecular ester
@cy
Salicylic acid bimolecular ester
@en
Salicyloxysalicylic acid
@cy
prefLabel
Salsalat
@sh
Salsalate
@nl
Salsalato
@es
Salsalato
@it
salsalad
@cy
salsalat
@nb
salsalat
@nn
salsalat
@sv
salsalate
@en
salsalate
@vi
P2175
P486
P592
P6366
P646
P661
P662
P665
P683
P1579
P2067
258.052823